First name*
Last name*
Email*
Company name*
Job title*
Mobile phone number*
How many people do you manage?* Please Select0-1010-5050-100100+
What are the primary scientific challenges faced by your projects over the next 6–12 months?*
How much budget have you allocated to support your project over the next 6-12 months?* Please SelectUnder 100k100k - 500k500k - 1m1m - 5m5m +
Which of the following areas are you likely to invest in over the next 6-12 months?* Novel targets beyond incretin biology validated by human genetic and clinical dataNon-incretin obesity and cardiometabolic mechanisms with differentiated efficacyMulti-agonist obesity therapeutics with cardiometabolic benefitOral obesity and cardiometabolic therapeuticsCombination therapies for obesity, cardiovascular, renal, and metabolic comorbiditiesTherapies improving weight loss quality, including lean-mass preservationBody-composition and fat-distribution biomarkers for therapeutic differentiationTranslational models linking preclinical weight loss to human outcomesHuman-relevant preclinical models for cardiovascular and renal complicationsPatient-stratification tools for heterogeneous obesity and cardiometabolic populationsBiomarkers predicting long-term cardiovascular, renal, and metabolic benefitFormulation and delivery technologies improving adherence and convenienceTolerability optimisation platforms for chronic obesity treatmentEfficient cardiovascular, renal, and metabolic outcomes trial design platformsReal-world evidence platforms for long-term cardiometabolic outcomes
Reasons for Investment?*
Would you be interested in moderating a roundtable discussion?* YesNo
Terms and Conditions I have read and agree to the Terms and Conditions
Δ